6G9M | Signaling Protein | date | Apr 11, 2018 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Fragment-Based Discovery Of A Highly Potent, Orally Bioavail Inhibitor Which Modulates The Phosphorylation And Catalytic Of Erk12 | ||||||||||||||
authors | M.O'Reilly | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Mitogen-Activated Protein Kinase 1 Chain: A Synonym: Mapk 1,Ert1,Extracellular Signal-Regulated Kinase Map Kinase Isoform P42,P42-Mapk,Mitogen-Activated Protein K Mapk 2; Ec: 2.7.11.24 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mapk1, Erk2, Prkm1, Prkm2 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.86 Å | ||||||||||||
ligand | CME, ESW, SO4 | enzyme | Transferase E.C.2.7.11.24 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Fragment-based discovery of a potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2., Heightman TD, Berdini V, Braithwaite H, Buck IM, Cassidy M, Castro J, Courtin A, Day JEH, East C, Fazal L, Graham B, Griffiths-Jones CM, Lyons JF, Martins V, Muench S, Munck JM, Norton D, O'Reilly M, Palmer N, Pathuri P, Reader M, Rees DC, Rich SJ, Richardson C, Saini H, Thompson NT, Wallis NG, Walton H, Wilsher NE, Woolford AJ, Cooke M, Cousin D, Onions S, Shannon J, Watts J, Murray CW, J Med Chem. 2018 May 18. doi: 10.1021/acs.jmedchem.8b00421. PMID:29775310 |
Data retrieval |
View 6G9M in 3D |
Visual 3D analysis of 6G9M |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6G9M |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |